
NHS to roll out DIY cervical cancer screening for women at home
The NHS is to roll out DIY cervical cancer screening at home.
Women who have consistently missed offers for screening will be offered the chance to 'self-sample' to help prevent cervical cancer.
Wes Streeting, the Health Secretary, said it was part of efforts to provide healthcare 'that works around people's lives '.
The Department of Health and Social Care said the new approach could potentially save around 5,000 lives a year in England.
Officials said the home-testing kits would be offered from January under the upcoming 10-year health plan, which is expected next week.
The plan was recommended by the UK National Screening Committee.
Mr Streeting said: 'These self-sampling kits represent healthcare that works around people's lives, not the other way around. They put women firmly in control of their own health, ensuring we catch more cancers at their earliest, most treatable stages.
'Our 10-year health plan will fundamentally reform the NHS, shifting focus from treating illness to preventing it before it starts.
'We know the earlier cancer is diagnosed the better the chances are of survival. By making screening more convenient, we're tackling the barriers that keep millions of women from potentially life-saving tests.'
The tests, which can be performed at home, look for the human papillomavirus (HPV), the virus which is linked to the majority of cases of cervical cancer.
The NHS offers cervical screening tests – previously known as smear tests – to all women aged 25 to 64 every three years.
But many women do not take up the offer, with a number citing a lack of time, discomfort or embarrassment.
Some five million women are not up to date with routine check-ups, according to data published by the NHS last November.
Under the initiative, women will be sent a self-sampling kit in the post which can be returned via pre-paid mail.
Those who are found to have the HPV virus will be encouraged to attend an in-person appointment with a clinician.
Health minister Karin Smyth said the move was 'a revolutionary shift in how we approach healthcare'.
She said many women did not attend cervical cancer screening appointments for understandable reasons – including 'embarrassment, cultural sensitivities, inconvenient services and busy lives'.
She wrote in The Telegraph: 'These simple kits test for HPV – the virus responsible for most cervical cancers – and can be used in the privacy of your own home. No awkward appointments, no time off work, no childcare arrangements needed.
'For those who haven't responded to screening invitations, these kits will be offered to you on your NHS app and at the push of a button, mailed to your home.'
A trial programme suggested that offering self-sampling kits to 'under-screened' women when they attend their GP practice, and posting kits to women's homes, could boost uptake in England by about 400,000 each year. The YouScreen trial was led by King's College London in partnership with NHS England.
NHS England said the new programme 'specifically targets those groups consistently missing vital appointments' including younger women, those from minority ethnic backgrounds, people with disabilities and LGBT+ people.
Dr Anita Lim, chief investigator of the YouScreen trial from King's College London, said: 'This is a significant step forward for cervical cancer prevention and brings us closer to the NHS goal of eliminating the disease by 2040.
'The YouScreen trial, which provided self-sampling HPV kits to under-screened women in London, demonstrated that self-sampling could reach people who find it difficult to attend traditional screening – including those from diverse and underserved populations.
'It's hugely positive to see this now reflected in national policy, helping more people get protected from this highly preventable cancer.'
Michelle Kane, NHS England's director of screening, said: 'There are a number of reasons that stop some women taking up the offer of screening and we hope the introduction of self-testing will encourage more women to take up this life-saving test in a way that works for them.
'I'd encourage anyone who gets an invite for a cervical screening, either from their local GP practice or the NHS App, to attend and if you have any worrying symptoms, please contact your GP. It could save your life.'
Early detection saves lives
By Karin Smyth
Despite having a family history of skin conditions, I was always too busy to pay attention to the warning signs. 'I'm not a sun worshipper,' I told myself as I rushed between meetings, caring for others and constituency commitments, never making time to get that changing mole checked.
It was only by chance that a consultant oncologist spotted a small lump on my face at a parliamentary event a few years ago that led me to a check-up. While that lump turned out to be benign, it led to discovering melanoma on my leg.
My experience taught me two vital lessons: early detection saves lives, and our healthcare system must work around people's lives, not the other way around.
That's why I'm so passionate about the announcement we're making today. Under our 10 Year Health Plan, women who have not taken up the offer of a cervical screening appointment will be offered a self-sample kit to be mailed to their home.
This isn't just another NHS initiative – it's a revolutionary shift in how we approach healthcare.
Currently, nearly a third of women miss their cervical screening appointments.
That's over five million people potentially putting themselves at risk. The reasons are understandable – embarrassment, cultural sensitivities, inconvenient services and busy lives do come in the way of attending appointments.
But cervical cancer doesn't care about your schedule. It claims lives that could be saved through early detection.
For those unable to attend appointments, self-sampling can allow women to take control back. These simple kits test for HPV – the virus responsible for most cervical cancers – and can be used in the privacy of your own home. No awkward appointments, no time off work, no childcare arrangements needed.
For those who haven't responded to screening invitations, these kits will be offered to you on your NHS App and at the push of a button, mailed to your home.
Anyone testing positive will be referred for follow-up assessment, ensuring the same high standards of care as traditional screening.
This initiative is just one piece of our broader vision outlined in the 10 Year Health Plan.
We're moving from treating sickness to preventing it, from hospital corridors to community spaces. Because true healthcare isn't about waiting until you're ill – it's about keeping you well in the first place.
I know first-hand the fear that comes with a cancer diagnosis. My melanoma journey could have been very different had I ignored that changing mole for longer.
Many women with cervical cancer face similar stories – symptoms noticed too late, screening appointments repeatedly postponed.
When I tell people to check their skin regularly or attend screening appointments, I'm not speaking from a position of privilege or ignorance. I'm speaking as someone who's faced that fear, someone who knows what's at stake.
Because when it comes to cancer, early detection isn't just preferable – it's the difference between life and death. And no one should miss that opportunity because the system wasn't designed with their needs in mind.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
38 minutes ago
- The Independent
Experimental drug could lead to substantial weight reduction
A new experimental drug, Maridebart cafraglutide (MariTide), shows promise for significant weight reduction and treating obesity and type 2 diabetes. Clinical trial results indicate MariTide can reduce body weight by up to 20 per cent within a year, with weight loss continuing beyond 12 months. The drug targets similar molecules as popular weight loss jabs like Ozempic and also affects insulin release, leading to improved heart health measures. MariTide's once-a-month or less frequent dosing schedule could enhance patient adherence and provide sustainable, long-term weight control. While some mild to moderate gut-related side effects were noted, they were manageable, and researchers are now exploring the drug's further efficacy and use in other conditions.


Daily Mirror
43 minutes ago
- Daily Mirror
Dame Judi Dench shares plea after watching loved ones 'slip away'
Estimates suggest that almost one million people are living with dementia in the UK, but one in three remain undiagnosed Dame Judi Dench is urging the Government to provide earlier NHS diagnosis for people with dementia. The Oscar-winning actress supports a new campaign and petition by Alzheimer's Research UK, advocating for quicker diagnosis of the condition. Nearly a million people in the UK live with dementia, yet approximately one in three remains undiagnosed. Alzheimer's Research UK reports that in certain parts of England, people can wait as long as a year for diagnosis after referral, with those in the most deprived regions experiencing even greater delays. Dame Judi, 90, said: "Dementia doesn't just take away memories – it can take away identity, connection, and the future you thought you had. Watching loved ones slip away, and not knowing why, is an experience no one should have to go through without answers. "Many people across the UK are still waiting far too long for a dementia diagnosis – or never receive one at all. That means they miss out on vital support, on the chance to plan ahead, opportunities to get involved in research, and on precious time. "A diagnosis may not fix everything, but it gives people understanding, clarity, and some control at a time when everything feels uncertain. It allows families to make the most of the moments they have left. "That's why I've signed Alzheimer's Research UK's petition – and why I'm asking the public to do the same. Together, we can call on Government to fix the crumbling diagnosis system and make sure no one faces dementia unseen." The new Alzheimer's Research UK campaign, Dementia Unseen, comes after the NHS target to ensure 66.7% of people with dementia receive a diagnosis was removed from NHS planning guidance for 2025-26. It is calling for people with suspected dementia to be referred by their GP to see a specialist within six weeks – and to have a diagnosis and treatment plan in place within 18 weeks. Hilary Evans-Newton, chief executive of Alzheimer's Research UK, said: "Everyone who has dementia should have the right to know the disease or diseases causing it, and to be diagnosed early enough to get treatments that help with its symptoms. "But hundreds of thousands of people are waiting too long for a diagnosis, causing uncertainty, and adding distress to an already challenging situation. "We're incredibly grateful to Dame Judi for helping shine a light on what people with dementia need – and to everyone who has already signed our petition and stands with us. "More people are seeking answers, so it's vital that the NHS and government act now to fix the system – because no one should face dementia alone or unseen." Professor Fiona Carragher, chief policy officer at Alzheimer's Society, also added: "Everyone living with dementia deserves the clarity and dignity of an early and accurate diagnosis. Yet, more than a third of people living with this terminal condition are in the dark because they haven't been diagnosed, with many left to struggle alone without the care, support and treatment a diagnosis can bring. "In fact, on average people experience dementia symptoms for three and a half years before they receive a diagnosis. For some time, we've been calling on the UK Government to urgently address dementia diagnosis and we welcome the recommendations in this new report. "In particular, we support the call for health services to have the right teams and technology they need to diagnose more people, and for more data on diagnosis so that resources can be targeted where they're needed most. "The science for dementia treatments is flying but the diagnosis system is failing. It is crucial governments invest in diagnosis across England, Wales and Northern Ireland so people can access the existing treatments of today, plan for the future, and be eligible for the life-changing treatments of tomorrow. "If our governments set bold and ambitious new dementia diagnosis rate targets to get more people diagnosed, this would bring significant benefits for individuals, their families, and for health and care services."

Western Telegraph
an hour ago
- Western Telegraph
Overlooking sexual harassment against health staff ‘risks patient safety'
Medics claim that overlooking these incidents allows other toxic behaviours 'to perpetuate'. It comes as members of the British Medical Association (BMA) called for NHS trusts to include active bystander training – which aims to equip people with the skills to challenge unacceptable conduct – in mandatory training programmes. Delegates at the union's annual representative meeting (ARM) in Liverpool also voted for the BMA to lobby for a national anonymous reporting system for victims of sexual harassment. Dr Helen Neary, co-chairwoman of the BMA consultants committee, said: 'People are bystanders at all levels, and a working culture that turns a blind eye to this behaviour is also a risk to patient safety, enabling other poor behaviours to perpetuate.' The motion urged NHS organisations to probe allegations of sexual misconduct using trained investigators external to the trust. Dr Neary added: 'No one should feel unsafe at work. Yet the appalling truth is that doctors, disproportionately women, are still subject to sexual harassment, abuse and assault in the workplace – often by their fellow doctors. This has to stop. 'Not only is it obviously completely unacceptable and has a devastating impact on victims, but also affects the quality of care and workforce capacity as poor behaviours will do nothing to retain staff in the NHS.' In March, the latest NHS staff survey found one in 12 (8.82%) of workers were the target of unwanted sexual behaviour such as offensive comments, touching and assaults. The proportion was similar to that reported in 2023 (8.79%) when the question was first asked as part of the survey. Last October, NHS England launched a new national sexual misconduct policy framework to ensure trusts had robust policies in place for staff to report incidents. Speaking to delegates at the BMA ARM in Liverpool, Professor Bhairavi Sapra said that while the framework is a 'very welcome first step', it is not mandatory. 'It is up to individual employers to adopt it, and even then, perpetrators can simply move on from one employer to another without accountability for those in positions of power to prevent this behaviour,' she added. 'Worse still, there is no national reporting mechanism. That means if someone wants to report an incident months later in a different workplace, they face an uphill battle, often alone. 'Survivors have told us why they don't come forward. They fear being told they're overreacting. 'They fear retaliation or reputational damage. They fear nothing will change, and sadly, they are not wrong. 'Investigations, when they do happen, are rarely trauma informed, often the process itself can feel like another form of harm.' Dr Neary said: 'As the trade union and professional association for all doctors in the UK – from those beginning their careers as medical students to retirement and beyond – the BMA welcomes the legal obligation placed on the NHS to protect employees from sexual harassment. 'This vote makes some excellent suggestions on how this work can go further, including anonymous reporting, that will encourage those concerned about coming forward to do so, and better equipping doctors on how they can support colleagues when they witness sexual harassment at work.' Prof Sapra also claimed the 'power imbalance' in the medical profession is 'stark', adding: 'Junior staff rely on senior medical staff for training, for references and for their very careers. 'That dependency makes them especially vulnerable and often silent.' An NHS England spokesperson said: 'It is totally unacceptable that NHS staff experience sexual misconduct or harassment at work – this behaviour has no place in the health service, and all organisations must take robust and compassionate action to prevent it. 'The NHS Sexual Safety Charter has been adopted by every Integrated Care Board and NHS Trust in England, which encourages consideration of external, independent investigators in complex or sensitive cases – and all NHS organisations should ensure that those leading these processes are properly trained to handle them with the seriousness and sensitivity they require.'